We are live on ! Find out more
PSTX

Poseida Therapeutics, Inc. Common Stock
PSTX

Delisted

PSTX was delisted on the 7th of January, 2025.

Back to rankings

1 hedge funds and large institutions have $308K invested in Poseida Therapeutics, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 113 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 115 → 1 (-114)

100% less capital invested

Capital invested by funds: $519M → $308K (-$519M)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 113

Holders
1
Holders Change
-114
Holders Change %
-99.13%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
113
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$96.1M
2
PCM
Pentwater Capital Management
Florida
-$82.8M
3
BlackRock
BlackRock
New York
-$54.1M
4
Nomura Holdings
Nomura Holdings
Japan
-$49.1M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$36.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
IIM
76
INTECH Investment Management
Florida
– -$211K -21,970 Closed
VOYA Investment Management
77
VOYA Investment Management
Georgia
– -$202K -21,042 Closed
GI
78
GAMCO Investors
Connecticut
– -$192K -20,000 Closed
Toronto Dominion Bank
79
Toronto Dominion Bank
Ontario, Canada
– -$192K -20,000 Closed
Prudential Financial
80
Prudential Financial
New Jersey
– -$192K -19,980 Closed
ProShare Advisors
81
ProShare Advisors
Maryland
– -$186K -19,334 Closed
BHCM
82
Brevan Howard Capital Management
Jersey
– -$158K -16,413 Closed
Balyasny Asset Management
83
Balyasny Asset Management
Illinois
– -$149K -15,562 Closed
PFSRSONJ
84
Police & Firemen's Retirement System of New Jersey
New Jersey
– -$139K -14,527 Closed
Simplex Trading
85
Simplex Trading
Illinois
– -$134K -14,032 Closed
Squarepoint
86
Squarepoint
New York
– -$134K -13,950 Closed
SFI
87
Susquehanna Fundamental Investments
Pennsylvania
– -$134K -13,927 Closed
GS
88
GTS Securities
New York
– -$132K -13,796 Closed
Creative Planning
89
Creative Planning
Kansas
– -$128K -13,303 Closed
RIL
90
Rothschild Investment LLC
Illinois
– -$116K -12,060 Closed
IC
91
IEQ Capital
California
– -$115K -12,000 Closed
WP
92
Westmount Partners
California
– -$106K -11,000 Closed
AQR Capital Management
93
AQR Capital Management
Connecticut
– -$102K -10,645 Closed
AIP
94
Ameritas Investment Partners
Nebraska
– -$68.9K -7,182 Closed
Royal Bank of Canada
95
Royal Bank of Canada
Ontario, Canada
– -$68K -7,079 Closed
Legal & General Group
96
Legal & General Group
United Kingdom
– -$62.5K -6,514 Closed
Group One Trading
97
Group One Trading
Illinois
– -$50.3K -5,235 Closed
California State Teachers Retirement System (CalSTRS)
98
California State Teachers Retirement System (CalSTRS)
California
– -$47.8K -4,975 Closed
BIG
99
Brooklyn Investment Group
New York
– -$39.8K -4,149 Closed
TRCT
100
Tower Research Capital (TRC)
New York
– -$32.1K -3,340 Closed
1 2 3
4
5

PSTX Hedge Fund Activity: Q1 2025 in Review

1 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Poseida Therapeutics, Inc. Common Stock (PSTX) for Q1 2025, worth a combined $308K — down 100% from $519M a quarter earlier.

Sellers outnumbered buyers: 113 funds closed out of PSTX and 0 opened new positions — a net loss of 113 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Fidelity Investments, exiting entirely with an estimated $96.1M sold.

  • 1 institutional investor held Poseida Therapeutics, Inc. Common Stock (PSTX) as of Q1 2025, down from 115 in Q4 2024.
  • Funds reported $308K of Poseida Therapeutics, Inc. Common Stock stock for Q1 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Poseida Therapeutics, Inc. Common Stock positions in Q1 2025 and 113 closed out, a net change of -113 holders.
  • The largest Poseida Therapeutics, Inc. Common Stock seller in Q1 2025 was Fidelity Investments, an estimated $96.1M sold.

Based on aggregated 13F filings for Q1 2025.